recall
saveMerck Sharp & Dohme LLC recall (Cls II)
December 31, 2025updated 6mo ago
community read0 votes
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03 — Reason: Presence of particulate matter: potential presence of metal particulates in the product. — Status: Ongoing
view source ↗Data sources
last refreshed 14m ago
Found something off?
same company · ±60 days · 6
- recallMerck Sharp & Dohme LLC recall (Cls II)Dec 31, 2025
- approvalsotatercept: WINREVAIR (SOTATERCEPT-CSRK) — FDA approvalDec 8, 2025
- approvalPOSACONAZOLE: NOXAFIL (POSACONAZOLE) — FDA approvalJan 27, 2026
- approvalPOSACONAZOLE: NOXAFIL (POSACONAZOLE) — FDA approvalJan 27, 2026
- approval(berahyaluronidase alfa + pembrolizumab): KEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalNov 21, 2025
- approvalpembrolizumab: KEYTRUDA (PEMBROLIZUMAB) — FDA approvalNov 21, 2025
🐶 often sniffed alongside
top 8- tagRecall3 co-mentions · 3 sources
- tagSmall Molecule2 co-mentions · 2 sources
- drugNOXAFIL POWDERMIX KIT2 co-mentions · 1 sources
- drugAPREPITANT2 co-mentions · 1 sources
- drugsuvorexant2 co-mentions · 1 sources
- drugNOXAFIL2 co-mentions · 1 sources
- company$OGNOrganon & Co.1 co-mentions · 1 sources
- companyNovo Nordisk Inc1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that